Inactive Instrument
DIAL BIORFD Stock Nasdaq Stockholm
Stocks
DIABIO BTA
SE0019173832
Biotechnology & Medical Research
| 1 day | +2.99% |
| Manager | Title | Age | Since |
|---|---|---|---|
Karin Wehlin
CEO | Chief Executive Officer | - | 23/11/2023 |
Fata Mrsic
DFI | Director of Finance/CFO | - | 14/06/2024 |
Emelie Danefur
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 41 | 01/01/2021 | |
| Chairman | 70 | 01/01/2021 | |
Kushagr Punyani
BRD | Director/Board Member | 35 | 01/01/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.99% | +15.00% | - | - | 705K | |
| -0.62% | +0.50% | +33.92% | +60.07% | 64.38B | |
| +0.35% | +3.04% | +12.64% | +83.62% | 56.16B | |
| +0.53% | +2.55% | +13.90% | +104.77% | 54.16B | |
| -2.81% | -3.95% | +22.72% | +48.57% | 45.33B | |
| -0.33% | -3.12% | +17.62% | +117.27% | 42.25B | |
| +0.55% | +1.93% | +229.73% | +928.00% | 40.78B | |
| +3.27% | +47.40% | +110.44% | +94.92% | 33.8B | |
| +1.22% | -1.39% | +13.92% | +46.95% | 32.25B | |
| -1.29% | -1.72% | +21.00% | -6.85% | 23.57B | |
| Average | +0.39% | +4.72% | +52.88% | +164.14% | 43.63B | |
| Weighted average by Cap. | +0.02% | +3.64% | +49.57% | +162.47% |
Employees
4
